Patent ID: 6319504
Filing Date: 2001-11-20
Classification: A61K,A61P,C07K,Y10S

Abstract:
An isolated peptide:(a) consisting essentially of a .beta.-hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, 48-145 and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, and 21-24 respectively);(b) excluding .beta.-hCG (SEQ ID NO:2) amino acids contiguous to said segment; and(c) having a therapeutic effect selected from the group consisting of anti-HIV effects, anti-Kaposi's sarcoma effects, and pro-hematopoietic effects.